Median Technologies
Valbonne
About Median Technologies
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $235.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Oct 2025)
- Ticker: epa:ALMDT
- Website: mediantechnologies.com
- Phone: +330493333777
Industries & Categories
Clinical Trials, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/median-technologies-3900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.